Comparison of standard carbidopa–levodopa and sustained‐release carbidopa–levodopa in parkinson's disease: Pharmacokinetic and quality‐of‐life measures

Rajesh Pahwa(University of Kansas Medical Center), William C. Koller(Stanford University), Kelly E. Lyons(University of Kansas Medical Center), F. Zwiebel(Park Nicollet Methodist Hospital), Paul Silverstein(Park Nicollet Methodist Hospital), Mary Robischon(Park Nicollet Methodist Hospital), D. McGuire(The University of Kansas Health System)
Movement Disorders
September 1, 1997
10.1002/mds.870120508
Cited by 30

Related Papers

Variable expression of Parkinson's disease
|Neurology|1990|1.3k
International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study
|Movement Disorders|2006|1.1k
An algorithm (decision tree) for the management of Parkinson’s disease (2001):
|Neurology|2001|714
Mitochondrial Polymorphisms Significantly Reduce the Risk of Parkinson Disease
|The American Journal of Human Genetics|2003|537
High‐frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor
|Annals of Neurology|1997|484